Honliv Healthcare’s IPO


O’Melveny & Myers LLP advised Honliv Healthcare Management Group Company Limited on the deal.

Honliv Healthcare Management Group Company Limited closed its Hong Kong IPO.

The IPO offering size was approximately HK$315 million (approximately US$41.3 million), prior to the exercise of the over-allotment option. Assuming full exercise of the over-allotment option, the offering size will be approximately HK$362 million (approximately US$46.7 million).

Honliv Health operates one of the largest for-profit private general hospitals in China, Henan Honliv Hospital. Located at Xinxiang City, Henan Province, Henan Honliv Hospital is the largest for-profit private general hospital in Central China. Among all the for-profit private general hospitals in China, Henan Honliv Hospital ranked third in terms of number of beds in operation as of December 31, 2019.

The O’Melveny team was led by Ke Geng (Picture), and Ke Zhu and included Ye Sun, Wendy Kan, Katherine Wang, Dave Chan and Liam Liu.

Involved fees earner: Ke Geng – O’Melveny & Myers LLP; Wendy Kan – O’Melveny & Myers LLP; Katherine Wang – O’Melveny & Myers LLP; Ke Zhu – O’Melveny & Myers LLP;

Law Firms: O’Melveny & Myers LLP;

Clients: Honliv Healthcare Management Group Company Limited;

Author: Michael Patrini